Sirolimus‐Eluting Coronary Stents

Pim J. de Feyter; Peter Smits; Benno J. Rensing; J. Vos; Willem J. van der Giessen; Georgios Sianos; Patrick W. Serruys

doi:10.1111/j.1540-8183.2002.tb01090.x

Letter2008

Drug-Eluting Stents vs. Coronary-Artery Bypass Grafting

Joost Daemen, Neville Kukreja, Patrick W. Serruys

New England Journal of Medicine

Article2003

The impact of sirolimus-eluting stents on the outcome of patients with bifurcation lesions

Kengo Tanabe, Pedro A. Lemos, Chi‐Hang Lee, Muzaffer Değertekin, Evelyn Regar, Akis C. Arampatzis, Ron T. van Domburg, Pim de Feyter, Willem J. van der Giessen, George Sianos, Pieter C. Smits, Paul Cummins, Arno Ruiter, Francesco Saia, Patrick W. Serruys

Journal of the American College of Cardiology

Article2013

New concepts in the design of drug-eluting coronary stents

Scot Garg, Christos V. Bourantas, Patrick W. Serruys

Nature Reviews Cardiology

Article2003

Multi-lesion culotte and crush bifurcation stenting with sirolimus-eluting stents: long-term angiographic outcome.

Joost Daemen, Pedro A. Lemos, Patrick W. Serruys

PubMed

Article2002

Drug-eluting stents in the treatment of atherosclerotic coronary heart disease.

Pedro A. Lemos, Evelyn Regar, Patrick W. Serruys

PubMed

Sirolimus‐Eluting Coronary Stents

Abstract

Discussion(0)

Related publications

Drug-Eluting Stents vs. Coronary-Artery Bypass Grafting

The impact of sirolimus-eluting stents on the outcome of patients with bifurcation lesions

New concepts in the design of drug-eluting coronary stents

Multi-lesion culotte and crush bifurcation stenting with sirolimus-eluting stents: long-term angiographic outcome.

Drug-eluting stents in the treatment of atherosclerotic coronary heart disease.